Page last updated: 2024-11-02

pentobarbital and Bronchopulmonary Dysplasia

pentobarbital has been researched along with Bronchopulmonary Dysplasia in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joss-Moore, LA1
Hagen-Lillevik, SJ1
Yost, C1
Jewell, J1
Wilkinson, RD1
Bowen, S1
Dahl, MJ1
Dong, L1
Wang, Z1
Presson, AP1
Zhang, C1
Null, DM1
Yoder, BA1
Albertine, KH1

Other Studies

1 other study available for pentobarbital and Bronchopulmonary Dysplasia

ArticleYear
Alveolar formation is dysregulated by restricted nutrition but not excess sedation in preterm lambs managed by noninvasive support.
    Pediatric research, 2016, Volume: 80, Issue:5

    Topics: Animal Nutritional Physiological Phenomena; Animals; Animals, Newborn; Apoptosis; Bronchopulmonary D

2016